Weekly Buzz: So far, Santa is Letting us Down
12 Health Care Stocks Moving In Friday's Pre-Market Session
Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store Continues
Catalyst Watch: Eyes on Electric Vehicle Deliveries, Retail Data and Housing Reads
Bristol-Myers Gets FDA Okay for Injectable Opdivo
Mesoblast Shareholder Offers 2M Ordinary Shares Represented By 200K ADSs On Nasdaq Under Symbol "MESO" And Australian Exchange As "MSB"; Company To Receive $9.06 Per ADS Upon Warrant Exercise, No Proceeds From ADS Sales